SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Oliver & Co who wrote (2271)10/10/1997 11:43:00 AM
From: Steve Fancy   of 6136
 
Hello Oliver, certainly the events of the week had an impact on holding AGPH down, but the stock has been weak at best since Wednesday morning. FWIW, the PPI caused the general market trouble this morning. The CPI is next Tuesday morning and the PPI has served as a fairly reliable indicator in recent months.

Perhaps a better question would be what would have happened if they had just met estimates, or a penny above. I hate to think.

I find it annoying that all the brokerage firms literally pushing AGPH have not responded on the wires to their earnings. Normally after a quarter like AGPH had, the analysts are tripping over themselves to be the first few to upgrade and reiterate buys.

Hopefully there's a hoard of buyers watching for signs of a bottom. Maybe we'll see a pop yet this afternoon in anticipation of more news and hopefully the long awaited analyst comments Monday after their upcoming conference.

Oliver, you're participation on the board is appreciated. Thanks.

sf
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext